{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:06:31Z","timestamp":1785513991831,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Molteni Farmaceutici"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40122-020-00195-z","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:30:16Z","timestamp":1600356616000},"page":"657-667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report"],"prefix":"10.1007","volume":"9","author":[{"given":"Domenico","family":"Alvaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto Tommaso","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7184-5519","authenticated-orcid":false,"given":"Flaminia","family":"Coluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Lugoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Marinangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Massazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"3","key":"195_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2009.0014","volume":"5","author":"T Bell","year":"2009","unstructured":"Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009;5(3):137\u201344.","journal-title":"J Opioid Manag."},{"key":"195_CR2","volume-title":"Opioid Induced constipation","author":"O Sizar","year":"2019","unstructured":"Sizar O, Gupta M. Opioid Induced constipation. Treasure Island: StatPearls, StatPearls Publishing; 2019."},{"issue":"8","key":"195_CR3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/2050640618786145","volume":"6","author":"V Andresen","year":"2018","unstructured":"Andresen V, Banerji V, Hall G, et al. The patient burden of opioid-induced constipation: new insights from a large, multinational survey in five European countries. United Eur Gastroenterol J. 2018;6(8):1254\u201366.","journal-title":"United Eur Gastroenterol J."},{"issue":"3","key":"195_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1049909106289068","volume":"23","author":"P Glare","year":"2006","unstructured":"Glare P, Walsh D, Sheehan D. The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain. Am J Hosp Palliat Care. 2006;23(3):229\u201335.","journal-title":"Am J Hosp Palliat Care."},{"key":"195_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sjpain.2015.12.005","volume":"11","author":"AM Drewes","year":"2016","unstructured":"Drewes AM, Munkholm P, Simren M, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group. Scand J Pain. 2016;11:11\u201322.","journal-title":"Scand J Pain."},{"issue":"4","key":"195_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","volume":"22","author":"AK Tuteja","year":"2010","unstructured":"Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil. 2010;22(4):424\u201330 (e96).","journal-title":"Neurogastroenterol Motil."},{"key":"195_CR7","doi-asserted-by":"publisher","first-page":"7942145","DOI":"10.1155\/2019\/7942145","volume":"2019","author":"K Troberg","year":"2019","unstructured":"Troberg K, Hakansson A, Dahlman D. Self-rated physical health and unmet healthcare needs among swedish patients in opioid substitution treatment. J Addict. 2019;2019:7942145. https:\/\/doi.org\/10.1155\/2019\/7942145.","journal-title":"J Addict."},{"issue":"16","key":"195_CR8","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1080\/14656566.2016.1232391","volume":"17","author":"F Lugoboni","year":"2016","unstructured":"Lugoboni F, Mirijello A, Zamboni L, et al. High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments. Expert Opin Pharmacother. 2016;17(16):2135\u201341.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"195_CR9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/2050640616659967","volume":"5","author":"P Ducrotte","year":"2017","unstructured":"Ducrotte P, Milce J, Soufflet C, et al. Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000 individuals. United European Gastroenterol J. 2017;5(4):588\u2013600.","journal-title":"United European Gastroenterol J."},{"issue":"12","key":"195_CR10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2036.2008.03689.x","volume":"27","author":"SF Cook","year":"2008","unstructured":"Cook SF, Lanza L, Zhou X, et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther. 2008;27(12):1224\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"195_CR11","unstructured":"National Institute for Health and Care Excellence. Costing statement: Naloxegol for treating opioid-induced constipation (TA345). 2015."},{"issue":"3","key":"195_CR12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11894-017-0560-2","volume":"19","author":"DM Brenner","year":"2017","unstructured":"Brenner DM, Stern E, Cash BD. Opioid-related constipation in patients with non-cancer pain syndromes: a review of evidence-based therapies and justification for a change in nomenclature. Curr Gastroenterol Rep. 2017;19(3):12.","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"195_CR13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015;9(5):358\u201367.","journal-title":"J Addict Med."},{"issue":"1","key":"195_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur Gastroenterol J. 2019;7(1):7\u201320.","journal-title":"United Eur Gastroenterol J."},{"issue":"3","key":"195_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2009.0015","volume":"5","author":"P Holzer","year":"2009","unstructured":"Holzer P, Ahmedzai SH, Niederle N, et al. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J Opioid Manag. 2009;5(3):145\u201351.","journal-title":"J Opioid Manag."},{"issue":"8","key":"195_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/00989134-20140501-01","volume":"40","author":"J Klein","year":"2014","unstructured":"Klein J, Holowaty S. Managing constipation: implementing a protocol in a geriatric rehabilitation setting. J Gerontol Nurs. 2014;40(8):18\u201327.","journal-title":"J Gerontol Nurs."},{"issue":"1","key":"195_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MCG.0000000000000246","volume":"49","author":"J Gaertner","year":"2015","unstructured":"Gaertner J, Siemens W, Camilleri M, et al. Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol. 2015;49(1):9\u201316.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"195_CR18","doi-asserted-by":"crossref","first-page":"451e1-3","DOI":"10.1016\/j.genhosppsych.2012.05.006","volume":"35","author":"F Cosci","year":"2013","unstructured":"Cosci F. \u201cBowel obsession syndrome\u201d in a patient with chronic constipation. Gen Hosp Psychiatry. 2013;35(4):451e1-3.","journal-title":"Gen Hosp Psychiatry."},{"issue":"4","key":"195_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-017-0554-0","volume":"19","author":"M Simren","year":"2017","unstructured":"Simren M, Palsson OS, Whitehead WE. Update on rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep. 2017;19(4):15.","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"195_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5056\/jnm16214","volume":"23","author":"MJ Schmulson","year":"2017","unstructured":"Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23(2):151\u201363.","journal-title":"J Neurogastroenterol Motil."},{"issue":"9","key":"195_CR21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2011.164","volume":"106","author":"NC Suares","year":"2011","unstructured":"Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582\u201391.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"195_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756283X15578608","volume":"8","author":"AD Nelson","year":"2015","unstructured":"Nelson AD, Camilleri M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Thera Adv Gastroenterol. 2015;8(4):206\u201320.","journal-title":"Thera Adv Gastroenterol."},{"issue":"3","key":"195_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bpa.2019.07.016","volume":"33","author":"GP Joshi","year":"2019","unstructured":"Joshi GP, Kehlet H. Postoperative pain management in the era of ERAS: an overview. Best Pract Res Clin Anaesthesiol. 2019;33(3):259\u201367.","journal-title":"Best Pract Res Clin Anaesthesiol."},{"issue":"11","key":"195_CR24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.spinee.2018.03.015","volume":"18","author":"N Jain","year":"2018","unstructured":"Jain N, Brock JL, Phillips FM, et al. Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion. Spine J. 2018;18(11):1989\u201398.","journal-title":"Spine J."},{"issue":"19","key":"195_CR25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/BRS.0000000000002609","volume":"43","author":"N Jain","year":"2018","unstructured":"Jain N, Phillips FM, Weaver T, et al. Preoperative chronic opioid therapy: a risk factor for complications, readmission, continued opioid use and increased costs after one- and two-level posterior lumbar fusion. Spine (Phila Pa 1976). 2018;43(19):1331\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","volume":"13","author":"F Coluzzi","year":"2017","unstructured":"Coluzzi F, Bifulco F, Cuomo A, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manag. 2017;13:1163\u201373.","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"195_CR27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.23736\/S0375-9393.19.13321-4","volume":"85","author":"JV Pergolizzi","year":"2019","unstructured":"Pergolizzi JV, Lequang JA, Passik S, et al. Using opioid therapy for pain in clinically challenging situations: questions for clinicians. Minerva Anestesiol. 2019;85(8):899\u2013908.","journal-title":"Minerva Anestesiol"},{"issue":"6","key":"195_CR28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0897190017732263","volume":"31","author":"JM Streicher","year":"2018","unstructured":"Streicher JM, Bilsky EJ. Peripherally acting mu-opioid receptor antagonists for the treatment of opioid-related side effects: mechanism of action and clinical implications. J Pharm Pract. 2018;31(6):658\u201369.","journal-title":"J Pharm Pract."},{"issue":"10","key":"195_CR29","first-page":"1932","volume":"18","author":"A Emmanuel","year":"2017","unstructured":"Emmanuel A, Johnson M, McSkimming P, et al. Laxatives do not improve symptoms of opioid-induced constipation: results of a patient survey. Pain Med. 2017;18(10):1932\u201340.","journal-title":"Pain Med."},{"issue":"1","key":"195_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-014-0254-6","volume":"35","author":"B Morlion","year":"2015","unstructured":"Morlion B, Clemens KE, Dunlop W. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone\/naloxone. Clin Drug Investig. 2015;35(1):1\u201311.","journal-title":"Clin Drug Investig."},{"issue":"5","key":"195_CR31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5414\/CP201646","volume":"50","author":"K Smith","year":"2012","unstructured":"Smith K, Hopp M, Mundin G, et al. Low absolute bioavailability of oral naloxone in healthy subjects. Int J Clin Pharmacol Ther. 2012;50(5):360\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/DDDT.S221278","volume":"14","author":"JV Pergolizzi Jr","year":"2020","unstructured":"Pergolizzi JV Jr, Christo PJ, LeQuang JA, et al. The use of peripheral mu-opioid receptor antagonists (PAMORA) in the management of opioid-induced constipation: an update on their efficacy and safety. Drug Des Dev Ther. 2020;14:1009\u201325.","journal-title":"Drug Des Dev Ther."},{"issue":"4","key":"195_CR33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1060028017739637","volume":"52","author":"JA Murphy","year":"2018","unstructured":"Murphy JA, Sheridan EA. Evidence based review of pharmacotherapy for opioid-induced constipation in noncancer pain. Ann Pharmacother. 2018;52(4):370\u20139.","journal-title":"Ann Pharmacother"},{"key":"195_CR34","unstructured":"Gazzetta Ufficiale della Republica Italiana Anno 161\u00b0 - Numero 111 del 30 Aprile 2020."},{"key":"195_CR35","volume-title":"Relistor\u00ae (methylnaltrexone bromide subcutaneous injection)","author":"Salix Pharmaceuticals Inc","year":"2014","unstructured":"Salix Pharmaceuticals Inc. Relistor\u00ae (methylnaltrexone bromide subcutaneous injection). Raleigh: Full Prescribing Information; 2014."},{"key":"195_CR36","volume-title":"Moventig\u00ae (naloxegol)","author":"AB AstraZeneca","year":"2015","unstructured":"AstraZeneca AB. Moventig\u00ae (naloxegol). S\u00f6dert\u00e4lje: Full Prescribing Information; 2015."},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2147\/JPR.S243435","volume":"13","author":"F Coluzzi","year":"2020","unstructured":"Coluzzi F, Scerpa MS, Pergolizzi J. Naldemedine: a new option for OIBD. J Pain Res. 2020;13:1209\u201322.","journal-title":"J Pain Res."},{"issue":"34","key":"195_CR38","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","volume":"35","author":"N Katakami","year":"2017","unstructured":"Katakami N, Harada T, Murata T, et al. Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer. J Clin Oncol. 2017;35(34):3859\u201366.","journal-title":"J Clin Oncol"},{"issue":"6","key":"195_CR39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/annonc\/mdy118","volume":"29","author":"N Katakami","year":"2018","unstructured":"Katakami N, Harada T, Murata T, et al. Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Ann Oncol. 2018;29(6):1461\u20137.","journal-title":"Ann Oncol"},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JPR.S175900","volume":"12","author":"Y Saito","year":"2019","unstructured":"Saito Y, Yokota T, Arai M, et al. Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies. J Pain Res. 2019;12:127\u201338.","journal-title":"J Pain Res"},{"issue":"11","key":"195_CR41","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40265-019-01160-7","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair HA. Naldemedine: a review in opioid-induced constipation. Drugs. 2019;79(11):1241\u20137.","journal-title":"Drugs."},{"issue":"2","key":"195_CR42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AJP.0000000000000662","volume":"35","author":"ER Viscusi","year":"2019","unstructured":"Viscusi ER. Clinical overview and considerations for the management of opioid-induced constipation in patients with chronic noncancer pain. Clin J Pain. 2019;35(2):174\u201388.","journal-title":"Clin J Pain"},{"key":"195_CR43","unstructured":"Cook SF, Bell T, Sweeny CT, et al. Impact on quality of life of constipation associated GI symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey, In: 26th Annual Scientific Meeting of the American Pain Society, 2007."},{"key":"195_CR44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/JPR.S105892","volume":"9","author":"M Duenas","year":"2016","unstructured":"Duenas M, Ojeda B, Salazar A, et al. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016;9:457\u201367.","journal-title":"J Pain Res."},{"issue":"8","key":"195_CR45","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1001\/amajethics.2019.636","volume":"21","author":"R Singh","year":"2019","unstructured":"Singh R, Pushkin GW. How Should medical education better prepare physicians for opioid prescribing? AMA J Ethics. 2019;21(8):E636\u201341.","journal-title":"AMA J Ethics."},{"issue":"1","key":"195_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1526-4637.2007.00250.x","volume":"8","author":"LM Frantsve","year":"2007","unstructured":"Frantsve LM, Kerns RD. Patient-provider interactions in the management of chronic pain: current findings within the context of shared medical decision making. Pain Med. 2007;8(1):25\u201335.","journal-title":"Pain Med."}],"updated-by":[{"DOI":"10.1007\/s40122-020-00204-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000}}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-020-00195-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-020-00195-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-020-00195-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:23:12Z","timestamp":1631834592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-020-00195-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1007\/s40122-020-00195-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40122-020-00204-1","asserted-by":"object"}]},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article can be found online.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}